Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Defining Best Management in Adult Chronic Rhinosinusitis
2018-001100-11Phase 4Unknown
- Sponsor
- University College London
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of clarithromycin in chronic rhinosinusitis (CRS) (3 arms), sponsored by University College London. Primary endpoint: Disease-specific health-related quality of life at six months. Status: unknown.
02
Drugs
clarithromycin
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on 2018-001100-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001100-11.